Trial Profile
A phase II study of radiotherapy (ERT) and concurrent gemcitabine-based chemotherapy with or without intraluminal brachytherapy (BT) in the patients with unresectable extrahepatic cholangiocarcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Feb 2016
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- 12 Feb 2016 New trial record
- 01 Feb 2016 Results published in the Anticancer Research